Caregility customers and healthcare institutions interested in integrating Eko into the Caregility telehealth platform can attend an educational webinar on August 25.


About Caregility

Caregility Corporation is dedicated to connecting patients and clinicians everywhere with its Caregility Cloud™ virtual care platform. Designated as the Best in KLAS Virtual Care Platform (non-EMR) in 2021 and 2022, Caregility Cloud™ powers a purpose-built ecosystem of enterprise telehealth solutions across the care continuum. Caregility provides secure, reliable, and HIPAA- compliant audio and video communication designed for any device and clinical workflow, in both acute and ambulatory settings. Caregility supports more than 1,300 hospitals across dozens of health systems with millions of virtual care sessions hosted annually. From critical and acute, to urgent and emergent, to post-acute and ambulatory, as well as hospital-to-home, Caregility is connecting care everywhere.


About Eko
Eko, a digital health company, is advancing how healthcare professionals detect and monitor heart and lung disease with its innovative suite of digital tools, patient and provider software, and AI-powered analysis. Its FDA-cleared platform is used by hundreds of thousands of healthcare professionals worldwide, allowing them to detect earlier and with higher accuracy, diagnose with more confidence, manage treatment effectively, and ultimately give their patients the best care possible. Eko is headquartered in Oakland, California, with over $125 million in funding from Highland Capital Partners, Questa Capital, Artis Ventures, DigiTx Partners, NTTVC, Morningside Technology Ventures Limited, Mayo Clinic, Sutter Health, and others.

Back to HCB News

Health IT Homepage